Literature DB >> 11230310

Endothelial dysfunction and xanthine oxidoreductase activity in rats with human renin and angiotensinogen genes.

E M Mervaala1, Z J Cheng, I Tikkanen, R Lapatto, K Nurminen, H Vapaatalo, D N Müller, A Fiebeler, U Ganten, D Ganten, F C Luft.   

Abstract

We examined whether xanthine oxidoreductase (XOR), a hypoxia-inducible enzyme capable of generating reactive oxygen species, is involved in the onset of angiotensin (Ang) II-induced vascular dysfunction in double-transgenic rats (dTGR) harboring human renin and human angiotensinogen genes. In 7-week-old hypertensive dTGR, the endothelium-mediated relaxation of noradrenaline (NA)-precontracted renal arterial rings to acetylcholine (ACh) in vitro was markedly impaired compared with Sprague Dawley rats. Preincubation with superoxide dismutase (SOD) improved the endothelium-dependent vascular relaxation, indicating that in dTGR, endothelial dysfunction is associated with increased superoxide formation. Preincubation with the XOR inhibitor oxypurinol also improved endothelium-dependent vascular relaxation. The endothelium-independent relaxation to sodium nitroprusside was similar in both strains. In dTGR, serum 8-isoprostaglandin F(2alpha), a vasoconstrictor and antinatriuretic arachidonic acid metabolite produced by oxidative stress, was increased by 100%, and the activity of XOR in the kidney was increased by 40%. Urinary nitrate plus nitrite (NO(x)) excretion, a marker of total body NO generation, was decreased by 85%. Contractile responses of renal arteries to Ang II, endothelin-1 (ET-1), and NA were decreased in dTGR, suggesting hypertension-associated generalized changes in the vascular function rather than a receptor-specific desensitization. Valsartan (30 mg/kg PO for 3 weeks) normalized blood pressure, endothelial dysfunction, and the contractile responses to ET-1 and NA. Valsartan also normalized serum 8-isoprostaglandin F(2alpha) levels, renal XOR activity, and, to a degree, NO(x) excretion. Thus, overproduction of Ang II in dTGR induces pronounced endothelial dysfunction, whereas the sensitivity of vascular smooth muscle cells to nitric oxide is unaltered. Ang II-induced endothelial dysfunction is associated with increased oxidative stress and vascular xanthine oxidase activity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11230310     DOI: 10.1161/01.hyp.37.2.414

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  29 in total

Review 1.  Regulation of antioxidant and oxidant enzymes in vascular cells and implications for vascular disease.

Authors:  Sven Wassmann; Kerstin Wassmann; Georg Nickenig
Journal:  Curr Hypertens Rep       Date:  2006-04       Impact factor: 5.369

Review 2.  Obstructive sleep apnea: the new cardiovascular disease. Part I: Obstructive sleep apnea and the pathogenesis of vascular disease.

Authors:  Rami Khayat; Brian Patt; Don Hayes
Journal:  Heart Fail Rev       Date:  2008-09-20       Impact factor: 4.214

3.  Immunosuppressive treatment protects against angiotensin II-induced renal damage.

Authors:  Dominik N Muller; Erdenechimeg Shagdarsuren; Joon-Keun Park; Ralf Dechend; Eero Mervaala; Franziska Hampich; Anette Fiebeler; Xinsheng Ju; Piet Finckenberg; Jürgen Theuer; Christiane Viedt; Joerg Kreuzer; Harald Heidecke; Hermann Haller; Martin Zenke; Friedrich C Luft
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

Review 4.  Reactive oxygen species: roles in blood pressure and kidney function.

Authors:  Christopher S Wilcox
Journal:  Curr Hypertens Rep       Date:  2002-04       Impact factor: 5.369

5.  Inhibition of angiotensin II induced endothelin-1 gene expression by 17-beta-oestradiol in rat cardiac fibroblasts.

Authors:  H-H Chao; J-J Chen; C-H Chen; H Lin; C-F Cheng; W-S Lian; Y-L Chen; S-H Juan; J-C Liu; J-Y Liou; P Chan; T-H Cheng
Journal:  Heart       Date:  2005-05       Impact factor: 5.994

Review 6.  Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol.

Authors:  Pál Pacher; Alex Nivorozhkin; Csaba Szabó
Journal:  Pharmacol Rev       Date:  2006-03       Impact factor: 25.468

Review 7.  Oxidative stress and hypertension: current concepts.

Authors:  Ana M Briones; Rhian M Touyz
Journal:  Curr Hypertens Rep       Date:  2010-04       Impact factor: 5.369

Review 8.  Redox control of renal function and hypertension.

Authors:  Ravi Nistala; Adam Whaley-Connell; James R Sowers
Journal:  Antioxid Redox Signal       Date:  2008-12       Impact factor: 8.401

9.  Milk Products Containing Bioactive Tripeptides Have an Antihypertensive Effect in Double Transgenic Rats (dTGR) Harbouring Human Renin and Human Angiotensinogen Genes.

Authors:  Tiina Jauhiainen; Taru Pilvi; Zhong Jian Cheng; Hannu Kautiainen; Dominik N Müller; Heikki Vapaatalo; Riitta Korpela; Eero Mervaala
Journal:  J Nutr Metab       Date:  2009-11-30

10.  Sequential activation of JAKs, STATs and xanthine dehydrogenase/oxidase by hypoxia in lung microvascular endothelial cells.

Authors:  Guansong Wang; Pin Qian; Fannie R Jackson; Guisheng Qian; Guangyu Wu
Journal:  Int J Biochem Cell Biol       Date:  2007-08-30       Impact factor: 5.085

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.